Image pharmaphorum Editor Debates & Insight Sponsored Available on demand: Establishing a Solid Foundation for Dig... Available on demand: Join us for a one-hour live webinar entitled Establishing a Solid Foundation for Digital Transformation. Debates & Insight Sponsored Transforming compliance with technology Debates & Insight Sponsored Available on demand: Social medical: The social media buzz a... Join us for a one-hour live webinar discussing the social media buzz around this year’s ASCO Annual Meeting. Debates & Insight Sponsored Available on demand: What's next for patient-centricity? This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy. Load more results
Debates & Insight Sponsored Available on demand: Establishing a Solid Foundation for Dig... Available on demand: Join us for a one-hour live webinar entitled Establishing a Solid Foundation for Digital Transformation.
Debates & Insight Sponsored Available on demand: Social medical: The social media buzz a... Join us for a one-hour live webinar discussing the social media buzz around this year’s ASCO Annual Meeting.
Debates & Insight Sponsored Available on demand: What's next for patient-centricity? This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy.
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
